Department of Gastrosurgical Research, Sahlgrenska University Hospital, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.
Department of Gastrosurgical Research, Sahlgrenska University Hospital, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden; Department of Research, Royal College of Surgeons of England, London, UK.
Lancet Diabetes Endocrinol. 2017 Mar;5(3):174-183. doi: 10.1016/S2213-8587(16)30424-7. Epub 2017 Jan 6.
BACKGROUND: Severe obesity in adolescence is associated with reduced life expectancy and impaired quality of life. Long-term benefits of conservative treatments in adolescents are known to be modest, whereas short-term outcomes of adolescent bariatric surgery are promising. We aimed to compare 5-year outcomes of adolescent surgical patients after Roux-en-Y gastric bypass with those of conservatively treated adolescents and of adults undergoing Roux-en-Y gastric bypass, in the Adolescent Morbid Obesity Surgery (AMOS) study. METHODS: We did a nationwide, prospective, non-randomised controlled study of adolescents (aged 13-18 years) with severe obesity undergoing Roux-en-Y gastric bypass at three specialised paediatric obesity treatment centres in Sweden. We compared clinical outcomes in adolescent surgical patients with those of matched adolescent controls undergoing conservative treatment and of adult controls undergoing Roux-en-Y gastric bypass. The primary outcome measure was change in BMI over 5 years. We used multilevel mixed-effect regression models to assess longitudinal changes. This trial is registered with ClinicalTrials.gov, number NCT00289705. FINDINGS: Between April, 2006, and May, 2009, 100 adolescents were recruited to the study, of whom 81 underwent Roux-en-Y gastric bypass (mean age 16·5 years [SD 1·2], bodyweight 132·8 kg [22·1], and BMI 45·5 kg/m [SD 6·1]). 80 matched adolescent controls and 81 matched adult controls were enrolled for comparison of outcomes. The change in bodyweight in adolescent surgical patients over 5 years was -36·8 kg (95% CI -40·9 to -32·8), resulting in a reduction in BMI of -13·1 kg/m (95% CI -14·5 to -11·8), although weight loss less than 10% occurred in nine (11%). Mean BMI rose in adolescent controls (3·3 kg/m, 95% CI 1·1-4·8) over the 5-year study period, whereas the BMI change in adult controls was similar to that in adolescent surgical patients (mean change -12·3 kg/m, 95% CI -13·7 to -10·9). Comorbidities and cardiovascular risk factors in adolescent surgical patients showed improvement over 5 years and compared favourably with those in adolescent controls. 20 (25%) of 81 adolescent surgical patients underwent additional abdominal surgery for complications of surgery or rapid weight loss and 58 (72%) showed some type of nutritional deficiency; health-care consumption (hospital attendances and admissions) was higher in adolescent surgical patients compared with adolescent controls. 20 (25%) of 81 adolescent controls underwent bariatric surgery during the 5-year follow-up. INTERPRETATION: Adolescents with severe obesity undergoing Roux-en-Y gastric bypass had substantial weight loss over 5 years, alongside improvements in comorbidities and risk factors. However, gastric bypass was associated with additional surgical interventions and nutritional deficiencies. Conventional non-surgical treatment was associated with weight gain and a quarter of patients had bariatric surgery within 5 years. FUNDING: Swedish Research Council; Swedish Governmental Agency for Innovation Systems; National Board of Health and Welfare; Swedish Heart and Lung Foundation; Swedish Childhood Diabetes Foundation; Swedish Order of Freemasons Children's Foundation; Stockholm County Council; Västra Götaland Region; Mrs Mary von Sydow Foundation; Stiftelsen Göteborgs Barnhus; Stiftelsen Allmänna Barnhuset; and the US National Institute of Diabetes, Digestive, and Kidney Diseases (National Institutes of Health).
背景:青少年重度肥胖与预期寿命缩短和生活质量受损有关。保守治疗在青少年中的长期益处被认为是有限的,而青少年减重手术的短期效果则很有前景。我们旨在比较青少年接受 Roux-en-Y 胃旁路手术后 5 年的结果,以及在青少年肥胖手术 (AMOS) 研究中接受保守治疗的青少年和接受 Roux-en-Y 胃旁路手术的成年人。
方法:我们在瑞典三个专门的儿科肥胖治疗中心进行了一项全国性、前瞻性、非随机对照研究,涉及接受 Roux-en-Y 胃旁路手术的 13-18 岁重度肥胖青少年。我们比较了青少年手术患者与接受保守治疗的匹配青少年对照组和接受 Roux-en-Y 胃旁路手术的成年对照组的临床结果。主要结局测量是 5 年内 BMI 的变化。我们使用多级混合效应回归模型来评估纵向变化。这项试验在 ClinicalTrials.gov 注册,编号为 NCT00289705。
结果:2006 年 4 月至 2009 年 5 月期间,招募了 100 名青少年参加研究,其中 81 名接受了 Roux-en-Y 胃旁路手术(平均年龄 16.5 岁[标准差 1.2],体重 132.8 公斤[22.1],BMI 45.5 公斤/米[标准差 6.1])。招募了 80 名匹配的青少年对照组和 81 名匹配的成年对照组来比较结果。青少年手术患者在 5 年内体重减轻 36.8 公斤(95%CI-40.9 至-32.8),体重指数降低 13.1 公斤/米(95%CI-14.5 至-11.8),尽管有 9 人(11%)体重减轻不到 10%。在 5 年的研究期间,青少年对照组的平均 BMI 增加了 3.3 公斤/米(95%CI 1.1-4.8),而成年对照组的 BMI 变化与青少年手术患者相似(平均变化-12.3 公斤/米,95%CI-13.7 至-10.9)。青少年手术患者的合并症和心血管危险因素在 5 年内得到改善,与青少年对照组相比表现良好。81 名青少年手术患者中有 20 名(25%)因手术或体重快速下降而接受了额外的腹部手术,58 名(72%)出现了某种类型的营养缺乏;与青少年对照组相比,青少年手术患者的医疗保健消费(就诊和住院)更高。81 名青少年对照组中有 20 名(25%)在 5 年随访期间接受了减重手术。
解释:接受 Roux-en-Y 胃旁路手术的青少年重度肥胖患者在 5 年内体重明显减轻,同时合并症和危险因素也有所改善。然而,胃旁路手术与额外的手术干预和营养缺乏有关。常规非手术治疗与体重增加有关,四分之一的患者在 5 年内接受了减重手术。
资金:瑞典研究委员会;瑞典政府创新系统署;国家卫生和福利委员会;瑞典心脏和肺基金会;瑞典儿童糖尿病基金会;瑞典共济会儿童基金会;斯德哥尔摩县议会;西约塔兰地区;玛丽·冯·叙多夫夫人基金会;哥德堡儿童福利院;阿特姆纳·巴恩休特基金会;国家糖尿病、消化和肾脏疾病研究所(美国国立卫生研究院)。
Lancet Diabetes Endocrinol. 2017-1-6
Lancet Child Adolesc Health. 2020-1-21
Lancet Diabetes Endocrinol. 2017-1-6
J Clin Invest. 2025-4-8
Obes Sci Pract. 2025-3-29
Medicina (Kaunas). 2024-12-26
JAMA Pediatr. 2025-3-1
Diabetes Care. 2016-6
N Engl J Med. 2016-4-13
N Engl J Med. 2016-1-14
N Engl J Med. 2015-10
Obesity (Silver Spring). 2015-10
Curr Atheroscler Rep. 2015-9